Skip to main content
Top
Published in:

04-07-2024 | Constipation | DDS-SIRC Cooperative Conferences

As the Worm Turns—A Rare Cause of Intestinal Obstruction

Authors: Eleonora Lori, Marco Pace, Augusto Lauro, Daniele Pironi, Marco Moretti, Andrea Ferroni, Domenico Tripodi, Maria Ludovica Costanzo, Flavio Forte, Salvatore Sorrenti

Published in: Digestive Diseases and Sciences | Issue 8/2024

Login to get access

Abstract

Background

Anisakiasis, a zoonotic disease caused by the nematode Anisakis, poses a significant concern for public health, particularly in regions with high consumption of raw or undercooked fish.

Case Presentation

We present a case report of a 41-year-old woman who developed severe abdominal symptoms, ultimately diagnosed with intestinal obstruction due to Anisakis infestation, requiring surgery. Despite the absence of prominent eosinophilia or specific radiological findings, the diagnosis was confirmed through histological examination, highlighting the importance of considering anisakiasis in patients with a history of raw seafood consumption.

Conclusion

The case underscores the diagnostic challenges associated with anisakiasis, emphasizing the need for increased awareness among healthcare professionals and the public regarding the risks of consuming raw or undercooked seafood. Effective management requires a multidisciplinary approach, including clinical assessment, imaging studies, and histological evaluation, to ensure timely diagnosis and appropriate treatment.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
As the Worm Turns—A Rare Cause of Intestinal Obstruction
Authors
Eleonora Lori
Marco Pace
Augusto Lauro
Daniele Pironi
Marco Moretti
Andrea Ferroni
Domenico Tripodi
Maria Ludovica Costanzo
Flavio Forte
Salvatore Sorrenti
Publication date
04-07-2024

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more